Product
Antithrombin
Aliases
Human plasma derived antithrombin
2 clinical trials
2 indications
Indication
Antithrombin DeficiencyIndication
PreeclampsiaClinical trial
Phase 3, Double-blind, Placebo-controlled, Multicentre Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary BypassStatus: Not yet recruiting, Estimated PCD: 2026-09-01
Clinical trial
A Phase 3, Randomized, Placebo-controlled, Double Blind Study of KW-3357 in Patients With Early Onset Severe PreeclampsiaStatus: Completed, Estimated PCD: 2023-05-17